Ashburn, United States
£10,000 - £50,000
12 years as CEO of a biotech company. Took it public on NASDAQ in 2014.
Broad pharmaceutical experience in drug delivery, technology development and commercialization. Clinical and regulatory as well as business development expertize.
Medical & Sciences
Property
Finance
AIN helps investors and entrepreneurs build lasting and profitable relationships to build better businesses and brighter futures.